|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||
|
||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s5AD37D7C-3BBA-11EF-9B8C-D80585CE164B&I=39IZM&T=&OP=Display&O=html&O1=12910550&O2=2560000000097621&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DPredictive%2520Biomarkers%2520for%2520Checkpoint%2520Immunotherapy%253A%2520Current%2520Status%2520and%2520Challenges%2520for%2520Clinical%2520Application%26rft.au%3DAdams%252C%2520Sylvia%26rft.au%3DTray%252C%2520Nancy%26rft.au%3DWeber%252C%2520Jeffrey%2520S%26rft.date%3D2018-10-01%26rft.eissn%3D2326-6074%26rft.epage%3D1128%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issue%3D10%26rft.jtitle%3DCancer%2520immunology%2520research%26rft.spage%3D1122%26rft.volume%3D6%26rft_id%3Dinfo%253Adoi%252F10.1158%252F2326-6066.CIR-18-0214%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-DOI-getDOI-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-SHERPA_RoMEO_LCL-getWebService-object,7-GOOGLE_SCHOLAR_FREE-getWebSearch-object,8-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.193529&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:12910550-s5AD37D7C-3BBA-11EF-9B8C-D80585CE164B" timestamp="2024-07-06T19:08:25Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:2560000000097621</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application</jnl:atitle>
<jnl:jtitle>Cancer Immunology Research</jnl:jtitle>
<jnl:date>2018-10-01</jnl:date>
<jnl:spage>1122</jnl:spage>
<jnl:epage>1128</jnl:epage>
<jnl:issn>2326-6066</jnl:issn>
<jnl:volume>6</jnl:volume>
<jnl:issue>10</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2326-6074</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:dee7475f7153df9f2e88efd92c8fcdb3c3f4daaf</ctx:identifier>
<ctx:identifier>urn:UUID:s5AD37D7C-3BBA-11EF-9B8C-D80585CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)